Back to All Events

IQ Webinar Series: In-Vitro Release of Long Acting Injectables

IQ Webinar Series: In-Vitro Release of Long Acting Injectables

May 9, 2023 - May 9, 2023


Location: Virtual

Venue: Webex Webinar

Join the IQ Dissolution Working Group for a 3-day, virtual public workshop on In-Vitro Release of Long-Acting Injectables on 2, 4, and 9 May from 10-1 PM ET.

Dissolution of long-acting injectables is a rapidly evolving area and new to most scientists in the field. Most literature and conference content focuses on formulation and biopharmaceutics (PK, etc.) This webinar series will focus on the development and use of dissolution / in-vitro release methods, including industry case studies and some of the latest academic research.

This is a public workshop. Membership in the IQ Consortium is not required to attend.

Speakers and Moderators

• Kate Harris, AstraZeneca
• Heather Mead, AstraZeneca
• Vasiliki Paraskevopoulou, AstraZeneca
• Johanna Milsmann, Boehringer Ingelheim
• Sharadvi Thati, Bristol Myers Squibb
• Dawen Kou, Genentech
• Krutika Harish Jain, Gilead
• David Curran, GSK
• Marieta Duvnjak Romic, Novartis
• Marta Venczel, Sanofi
• Talia Flanagan, UCB
• Adam McCartan, University of Bath
• Randy Mrsny, University of Bath
• Nikoletta Fotaki, University of Bath
• Diane Burgess, University of Connecticut

Session 1: 02 May

Session 2: 04 May

Session 3: 09 May